- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03974802
Refitting Somofilcon A Sphere Contact Lens Wearers Into Fanfilcon A Sphere Lenses for 4-Weeks of Wear
August 6, 2020 updated by: Coopervision, Inc.
The aim of this subject-masked prospective study is to evaluate the clinical performance of habitual wearers of Clariti Elite sphere lenses after a refit with Avaira Vitality sphere lenses.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The aim of this subject-masked prospective study is to evaluate the clinical performance of habitual wearers of Clariti Elite sphere lenses after a refit with Avaira Vitality sphere lenses for 4 weeks of daily wear.
Study Type
Interventional
Enrollment (Actual)
41
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Mexico City, Mexico, 54090
- Optometry Clinic, National Autonomous University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 40 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Is between 18 and 40 years of age (inclusive)
- Has had a self-reported visual exam in the last two years
- Is an adapted soft contact lens wearer
- Has a contact lens spherical prescription between - 0.25 to - 8.00 (inclusive)
- Have no less than -0.75D of astigmatism in both eyes.
- Can achieve best corrected spectacle distance visual acuity of 20/25 (0.10 logMAR) or better in each eye.
- Can achieve a distance visual acuity of 20/30 (0.18 logMAR) or better in each eye with the study contact lenses.
- Has clear corneas and no active ocular disease
- Has read, understood and signed the information consent letter.
- Patient contact lens refraction should fit within the available parameters of the study lenses.
- Is willing to comply with the wear schedule (at least 5 days per week, > 8 hours/day assuming there are no contraindications for doing so).
- Is willing to comply with the visit schedule
Exclusion Criteria:
- Has a CL prescription outside the range of the available parameters of the study lenses.
- Has a spectacle cylinder of ≥ 1.00D in either eye.
- Has a history of not achieving comfortable CL wear (5 days per week; > 8 hours/day)
- Has contact lens best corrected distance vision worse than 20/25 (0.10 logMAR) in either eye.
- Presence of clinically significant (grade 2-4) anterior segment abnormalities
- Presence of ocular or systemic disease or need of medications which might interfere with contact lens wear.
Slit lamp findings that would contraindicate contact lens wear such as:
- Pathological dry eye or associated findings
- Pterygium, pinguecula, or corneal scars within the visual axis
- Neovascularization > 0.75 mm in from of the limbus
- Giant papillary conjunctivitis (GCP) worse than grade 1
- Anterior uveitis or iritis (past or present)
- Seborrheic eczema, Seborrheic conjunctivitis
- History of corneal ulcers or fungal infections
- Poor personal hygiene
- Has a known history of corneal hypoesthesia (reduced corneal sensitivity)
- Has aphakia, keratoconus or a highly irregular cornea.
- Has Presbyopia or has dependence on spectacles for near work over the contact lenses.
- Has undergone corneal refractive surgery.
- Is participating in any other type of eye related clinical or research study.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: somofilcon A (habitual) lens, then fanfilcon A (test) lens
Participants are habitual wearers of somofilcon A lens and refitted with fanfilcon A lens.
|
Contact Lens
Other Names:
Contact Lens
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Lens Centration for Somofilcon A (Habitual) Lens
Time Frame: Baseline
|
Lens Centration was measured using a 3-point scale (1=optimal centration, 2=decentration acceptable, 3=decentration unacceptable).
|
Baseline
|
Lens Centration for Somofilcon A (Habitual) Lens
Time Frame: 4- weeks
|
Lens Centration was measured using a 3-point scale (1=optimal centration, 2=decentration acceptable, 3=decentration unacceptable).
|
4- weeks
|
Lens Centration for Fanfilcon A (Test) Lens
Time Frame: Baseline
|
Lens Centration was measured using a 3-point scale (1=optimal centration, 2=decentration acceptable, 3=decentration unacceptable).
|
Baseline
|
Lens Centration for Fanfilcon A (Test) Lens
Time Frame: 2-weeks
|
Lens Centration was measured using a 3-point scale (1=optimal centration, 2=decentration acceptable, 3=decentration unacceptable).
|
2-weeks
|
Lens Centration for Fanfilcon A (Test) Lens
Time Frame: 4- weeks
|
Lens Centration was measured using a 3-point scale(1=optimal centration, 2=decentration acceptable, 3=decentration unacceptable).
|
4- weeks
|
Lens Corneal Coverage for Somofilcon A (Habitual) Lens
Time Frame: Baseline
|
Lens Corneal Coverage was rated as either Yes or No (Yes = full corneal coverage all time / no= incomplete corneal coverage)
|
Baseline
|
Lens Corneal Coverage for Somofilcon A (Habitual) Lens
Time Frame: 4 -weeks
|
Lens Corneal Coverage was rated as either Yes or No (Yes = full corneal coverage all time / no= incomplete corneal coverage)
|
4 -weeks
|
Lens Corneal Coverage for Fanfilcon A (Test) Lens
Time Frame: Baseline
|
Lens Corneal Coverage was rated as either Yes or No (Yes = full corneal coverage all time / no= incomplete corneal coverage)
|
Baseline
|
Lens Corneal Coverage for Fanfilcon A (Test) Lens
Time Frame: 2-weeks
|
Lens Corneal Coverage was rated as either Yes or No (Yes = full corneal coverage all time / no= incomplete corneal coverage)
|
2-weeks
|
Lens Corneal Coverage for Fanfilcon A (Test) Lens
Time Frame: 4-weeks
|
Lens Corneal Coverage was rated as either Yes or No (Yes = full corneal coverage all time / no= incomplete corneal coverage)
|
4-weeks
|
Percentage of Lens Tightness for Somofilcon A (Habitual) Lens
Time Frame: Baseline
|
Lens Tightness: Push Up Test measured by 0% to 100% continuous scale (0%-falls from cornea without lid support, 50% = optimum, and 100% = no movement)
|
Baseline
|
Percentage of Lens Tightness for Somofilcon A (Habitual) Lens
Time Frame: 4-Weeks
|
Lens Tightness: Push Up Test measured by 0% to 100% continuous scale (0%-falls from cornea without lid support, 50% = optimum, and 100% = no movement)
|
4-Weeks
|
Percentage of Lens Tightness for Fanfilcon A (Test) Lens
Time Frame: Baseline
|
Lens Tightness: Push Up Test measured by 0% to 100% continuous scale (0%-falls from cornea without lid support, 50% = optimum, and 100% = no movement)
|
Baseline
|
Percentage of Lens Tightness for Fanfilcon A (Test) Lens
Time Frame: 2-Weeks
|
Lens Tightness: Push Up Test measured by 0% to 100% continuous scale (0%-falls from cornea without lid support, 50% = optimum, and 100% = no movement)
|
2-Weeks
|
Percentage of Lens Tightness for Fanfilcon A (Test) Lens
Time Frame: 4-Weeks
|
Lens Tightness: Push Up Test measured by 0% to 100% continuous scale (0%-falls from cornea without lid support, 50% = optimum, and 100% = no movement)
|
4-Weeks
|
Post-Blink Movement for Somofilcon A (Habitual) Lens
Time Frame: Baseline
|
Post-Blink movement was measured on a scale 0-4 (0=Insufficient, unacceptable movement, 4 = Excessive, unacceptable movement)
|
Baseline
|
Post-Blink Movement for Somofilcon A (Habitual) Lens
Time Frame: 4-weeks
|
Post-Blink movement was measured on a scale 0-4 (0=Insufficient, unacceptable movement, 4 = Excessive, unacceptable movement)
|
4-weeks
|
Post-Blink Movement for Fanfilcon A (Test) Lens
Time Frame: Baseline
|
Post-Blink movement was measured on a scale 0-4 (0=Insufficient, unacceptable movement, 4 = Excessive, unacceptable movement)
|
Baseline
|
Post-Blink Movement for Fanfilcon A (Test) Lens
Time Frame: 2-weeks
|
Post-Blink movement was measured on a scale 0-4 (0=Insufficient, unacceptable movement, 4 = Excessive, unacceptable movement)
|
2-weeks
|
Post-Blink Movement for Fanfilcon A (Test) Lens
Time Frame: 4-weeks
|
Post-Blink movement was measured on a scale 0-4 (0=Insufficient, unacceptable movement, 4 = Excessive, unacceptable movement)
|
4-weeks
|
Overall Lens Fit Acceptance for Somofilcon A (Habitual) Lens
Time Frame: Baseline
|
Overall fit acceptance was measured using a scale of 0-4 (0= should not be worn, 1 = borderline but unacceptable, 2 = min.
acceptable, early review, 3 = not perfect but OK to dispense, and 4 = perfect)
|
Baseline
|
Overall Lens Fit Acceptance for Somofilcon A (Habitual) Lens
Time Frame: 4-weeks
|
Overall fit acceptance was measured using a scale of 0-4 (0= should not be worn, 1 = borderline but unacceptable, 2 = min.
acceptable, early review, 3 = not perfect but OK to dispense, and 4 = perfect)
|
4-weeks
|
Overall Lens Fit Acceptance for Fanfilcon A (Test) Lens
Time Frame: Baseline
|
Overall fit acceptance was measured using a scale of 0-4 (0= should not be worn, 1 = borderline but unacceptable, 2 = min.
acceptable, early review, 3 = not perfect but OK to dispense, and 4 = perfect)
|
Baseline
|
Overall Lens Fit Acceptance for Fanfilcon A (Test) Lens
Time Frame: 2-weeks
|
Overall fit acceptance was measured using a scale of 0-4 (0= should not be worn, 1 = borderline but unacceptable, 2 = min.
acceptable, early review, 3 = not perfect but OK to dispense, and 4 = perfect)
|
2-weeks
|
Overall Lens Fit Acceptance for Fanfilcon A (Test) Lens
Time Frame: 4-weeks
|
Overall fit acceptance was measured using a scale of 0-4 (0= should not be worn, 1 = borderline but unacceptable, 2 = min.
acceptable, early review, 3 = not perfect but OK to dispense, and 4 = perfect)
|
4-weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Average Daily Wearing Time - Somofilcon A (Habitual) Lens
Time Frame: 4-weeks
|
Average Daily Wearing Time for somofilcon A (Habitual) lens - measured by time hours/day
|
4-weeks
|
Average Daily Wearing Time - Fanfilcon A (Test) Lens
Time Frame: 2-weeks
|
Average daily wearing time for fanfilcon A (test) lens was measured in hours/day
|
2-weeks
|
Average Daily Wearing Time - Fanfilcon A (Test) Lens
Time Frame: 4-weeks
|
Average daily wearing time for fanfilcon A (test) lens was measured in hours/day
|
4-weeks
|
Average Comfortable Wearing Time - Somofilcon A (Habitual) Lens
Time Frame: 4 weeks
|
Average Comfortable Wearing Time - somofilcon A (habitual) Lens measured in hours/day.
Assessed using typical time of day when subject first experiences lens awareness or irritation.
|
4 weeks
|
Average Comfortable Wearing Time - Fanfilcon A (Test) Lens
Time Frame: 2 weeks
|
Average Comfortable Wearing Time - fanfilcon A (test) Lens measured in hours/day.
Assessed using typical time of day when subject first experiences lens awareness or irritation.
|
2 weeks
|
Average Comfortable Wearing Time - Fanfilcon A (Test) Lens
Time Frame: 4 weeks
|
Average Comfortable Wearing Time - fanfilcon A (test) Lens measured in hours/day.
Assessed using typical time of day when subject first experiences lens awareness or irritation.
|
4 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Ruben Velázquez Guerrero, MSc., FIACLE, School of Optometry, National Autonomous University (UNAM), Mexico City
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 14, 2019
Primary Completion (Actual)
July 24, 2019
Study Completion (Actual)
August 28, 2019
Study Registration Dates
First Submitted
June 3, 2019
First Submitted That Met QC Criteria
June 3, 2019
First Posted (Actual)
June 5, 2019
Study Record Updates
Last Update Posted (Actual)
August 18, 2020
Last Update Submitted That Met QC Criteria
August 6, 2020
Last Verified
August 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- EX-MKTG-101
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
product manufactured in and exported from the U.S.
Yes
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Myopia
-
Shanghai Eye Disease Prevention and Treatment CenterNot yet recruiting
-
Beijing Airdoc Technology Co., Ltd.Recruiting
-
Shanghai Eye Disease Prevention and Treatment CenterRecruiting
-
Beijing Airdoc Technology Co., Ltd.The First People's Hospital of XuzhouRecruiting
-
Universidad Complutense de MadridCooperativa de Ensino Superior, Politécnico e Universitário; Novovision; Instituto... and other collaboratorsActive, not recruiting
-
Nova Southeastern UniversityWithdrawnMyopia, Progressive
-
Shanghai Eye Disease Prevention and Treatment CenterShanghai General Hospital, Shanghai Jiao Tong University School of MedicineEnrolling by invitationHigh Myopia | Pathologic MyopiaChina
-
National Taiwan University HospitalUnknown
-
He Eye HospitalNot yet recruiting
-
University of BradfordCoopervision, Inc.; University of HuddersfieldNot yet recruiting
Clinical Trials on somofilcon A contact lens
-
Coopervision, Inc.Completed
-
Coopervision, Inc.Completed
-
Coopervision, Inc.CompletedAmetropiaUnited Kingdom
-
Coopervision, Inc.CompletedMyopiaUnited Kingdom
-
Coopervision, Inc.Completed
-
Coopervision, Inc.Completed
-
CIBA VISIONCompleted
-
Coopervision, Inc.CompletedMyopiaUnited States
-
CIBA VISIONUniversity of WaterlooCompleted
-
Alcon ResearchCompleted